Eduardo Sanchez

New data on state-level disparities in heart disease raise caution, but can be used for good

Eduardo Sanchez, M.D., M.P.H., Chief Medical Officer for Prevention and Chief of the Centers for Health Metrics and Evaluation, American Heart Association A geographic analysis published this week offers new insights – some positive, some concerning – about state-level differences in lost health from cardiovascular diseases (CVD). The positive: The burden of CVD improved in

Lee Schwamm photo

Improving Access to Stroke Treatment: Six Key Points the Wall Street Journal Missed

Lee H. Schwamm, M.D., FAHA, FANA, Executive Vice Chairman, Neurology Department, and Director, Comprehensive Stroke Center and Center for TeleHealth, Massachusetts General Hospital; Professor of Neurology, Harvard Medical School A February 6 article in the Wall Street Journal, “A Breakthrough Stroke Treatment Can Save Lives – If It’s Available” raised awareness of barriers that hinder

Laxmi Mehta photo

Where Heart Disease and Breast Cancer Intersect: Promoting Positive Outcomes For Both

Laxmi Mehta, M.D., FACC, FAHA, Section Director of Preventative Cardiology and Women’s Cardiovascular Health, Sarah Ross Soter Endowed Chair in Women’s Cardiovascular Health and Associate Professor of Medicine, The Ohio State University; Chair, Writing Group, AHA Scientific Statement on Cardiovascular Disease and Breast Cancer: Where these Entities Intersect Breast cancer patients may benefit from a

Eduardo Sanchez

Prevention Is Worth It

Eduardo Sanchez, M.D., M.P.H., Chief Medical Officer for Prevention and Chief of the Centers for Health Metrics and Evaluation, American Heart Association A better headline would have been “Preventive Care; Sometimes Good Things Cost Money.” Examples in the January 29, 2018 New York Times column, “Preventive Care Saves Money? Sorry, It’s Too Good to Be

Eduardo Sanchez

Adversity In Childhood and Adolescence Sets Stage for Cardiometabolic Outcomes

Eduardo Sanchez, M.D., M.P.H., Chief Medical Officer for Prevention and Chief of the Centers for Health Metrics and Evaluation, American Heart Association The phrase, “So, tell me about your childhood,” may sound cliché, but it might help us better understand cardiometabolic diseases in adults. Adverse experiences in childhood and adolescence are emotionally difficult, but to

Elliott Antman

Equitable Access to Life-Saving Treatments is Threatened by the Cost of Drugs to Patients

Elliott M. Antman, M.D., FAHA; Senior Physician, Brigham and Women’s Hospital; Associate Dean for Clinical and Translational Research, Harvard Medical School; Past President, American Heart Association As healthcare costs continue rising, escalating spending on pharmaceuticals warrants serious attention from healthcare stakeholders. In 2015, U.S. pharmaceuticals spending reached $309.5 billion, an increase of 8.5 percent from